Publication | Closed Access

Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin

OncologyChemotherapy-induced NauseaEmetogenic Chemotherapy RegimenCancer ManagementPharmacologyPharmacotherapyCancer TreatmentMedicine